Knowledge is key to face any disease, but there are few baseline studies from the beginning of the COVID-19 pandemic. The objective was to determine the association between being a vulnerable population and the low knowledge of the population in 17 Peruvian cities at the beginning of the pandemic. Knowledge was measured using a nine-question scale, which asks about the mechanism, symptoms and consequences; this was crosschecked against socio-demographic variables using analytical statistics. Of the 3913 respondents, the lowest knowledge was about how to react to cold symptoms and what treatment a person with an initial non-severe coronavirus infection should follow (37% and 53% correct answers; respectively). In the multivariate analysis, those who had lower percentages of a poor level of knowledge of the disease were those with higher education (aPR: 0.74; 95%CI: 0.62-0.88; p-value=0.001), among those with some postgraduate studies (aPR: 0.59; 95%CI: 0.43-0.68; p-value<0.001), among those who were part of the health personnel (aPR: 0.15; 95%CI: 0.05-0.46; p-value=0.001) and among women (aPR: 0.84; 95%CI: 0.73-0.96; p-value=0.009), on the other hand, the older the age, the worse the level of knowledge of the disease (aPR: 1.012; 95%CI: 1.005-1.018; p-value=0.001), adjusted by 4 variables. There was a low level of knowledge in some aspects and this is associated with some specific characteristics according to being considered a vulnerable population.
|Translated title of the contribution||Association between being a vulnerable population and low level of knowledge about COVID-19 in 17 cities of Peru at the beginning of the pandemic|
|Number of pages||9|
|Journal||Boletin de Malariologia y Salud Ambiental|
|State||Indexed - Sep 2021|
Bibliographical noteFunding Information:
FUNDING INFORMATION The work from the Taiwanese research team was supported by the grants from National Taiwan University Hospital (106-N3626, 107-S3816, and 107-N4041), the Ministry of Science and Technology, Executive Yuan, Taiwan (MOST 105-2314- B- 303- 008 and MOST 106-2314- B- 002- 136), National Health Research Institutes (NHRI-EX108- 10807BC), and Gilead Sciences (IN-TW- 988- 5987)
The work from the Taiwanese research team was supported by the grants from National Taiwan University Hospital (106‐N3626, 107‐S3816, and 107‐N4041), the Ministry of Science and Technology, Executive Yuan, Taiwan (MOST 105‐2314‐B‐303‐008 and MOST 106‐2314‐B‐002‐136), National Health Research Institutes (NHRI‐EX108‐10807BC), and Gilead Sciences (IN‐TW‐988‐5987)
© 2021 Instituto de Altos Estudios de Salud Publica. All rights reserved.